Cash Flow from Operating Activities: A company's cash flows from operations.
Takeda Pharmaceutical Co. (TAK) had Cash Flow from Operating Activities of $4.94B for the most recently reported fiscal year, ending 2024-03-31.
| Income Statement Financials | |
$29.42B |
|
$994.06M |
|
$9.84B |
|
$19.58B |
|
$27.94B |
|
$1.48B |
|
$-1.11B |
|
$364.26M |
|
$364.26M |
|
$994.96M |
|
$994.96M |
|
$994.96M |
|
$994.96M |
|
$1.48B |
|
$6.50B |
|
3.13B |
|
3.16B |
|
$0.32 |
|
$0.31 |
|
| Balance Sheet Financials | |
$17.65B |
|
$13.73B |
|
$86.60B |
|
$104.25B |
|
$15.96B |
|
$30.89B |
|
$38.10B |
|
$54.06B |
|
$50.19B |
|
$-16.63B |
|
$50.19B |
|
3.14B |
|
| Cash Flow Statement Financials | |
|
Cash Flow from Operating Activities |
$4.94B |
$-3.20B |
|
$-2.45B |
|
$3.68B |
|
$3.16B |
|
$-522.54M |
|
$489.01M |
|
$-1.98B |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|